SAAFY yields 82.07% · PFE yields 6.13%● Live data
📍 SAAFY pulled ahead of the other in Year 1
Combined, SAAFY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SAAFY + PFE for your $10,000?
Saras S.p.A. engages in the oil refinery business in Italy and internationally. The company operates through Industrial & Marketing and Renewables segments. It also sells and distributes oil products, such as diesel, gasoline, diesel fuel for heating, liquefied petroleum gas, virgin naphtha, bunkering, and aviation fuel. In addition, the company generates and sells electricity through an integrated gasification combined cycle plant with a total installed capacity of 575 megawatts; and a wind farm with a total installed capacity of 171 megawatts. Further, it provides consultancy, engineering, and technological development services in the oil refining, petrochemical, chemical, and energy industry sectors. Additionally, the company owns and operates depots located in Arcola and Cartagena. Saras S.p.A. was founded in 1962 and is headquartered in Milan, Italy.
Full SAAFY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.